Sun Pharma Advanced Research Company Limited (NSE:SPARC)

NSE:SPARC Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	63,837	37,284	48,000	119,521	58,203	80,734
Market Cap Growth	33.94%	-22.32%	-59.84%	105.35%	-27.91%	116.74%
Enterprise Value	69,418	41,441	48,951	116,002	60,088	81,455
Last Close Price	196.71	114.89	147.91	368.30	179.35	296.95

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	4.03	2.40	-	-	-	-
Forward PE	-	91.22	91.22	91.22	91.22	91.22
PS Ratio	3.34	1.98	66.88	158.21	24.38	58.82
PB Ratio	4.77	2.79	-22.12	95.04	11.35	258.55
P/TBV Ratio	5.04	2.94	-	143.93	11.94	995.49

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.64	2.21	68.21	153.55	25.17	59.35
EV/EBITDA Ratio	4.27	2.58	-	-	-	-
EV/EBIT Ratio	4.29	2.59	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.42	0.42	-1.24	0.49	0.03	2.54
Debt / EBITDA Ratio	0.34	0.35	-	-	-	-
Net Debt / Equity Ratio	0.42	0.42	-1.23	-0.76	-0.75	2.12
Net Debt / EBITDA Ratio	0.34	0.35	-0.82	0.24	1.80	-0.35
Net Debt / FCF Ratio	-	-2.12	-0.72	0.21	4.58	-0.28
Asset Turnover	-	1.50	0.17	0.11	0.43	0.54
Inventory Turnover	-	13.41	17.60	28.64	26.43	25.15
Quick Ratio	-	0.01	0.05	0.81	2.47	0.25
Current Ratio	-	2.47	0.07	1.02	2.54	0.42
Return on Equity (ROE)	-	276.89%	-	-121.28%	-81.83%	-
Return on Assets (ROA)	-	79.74%	-49.09%	-38.24%	-25.18%	-48.08%
Return on Capital Employed (ROCE)	-	112.90%	863.10%	-164.60%	-34.30%	-180.50%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	24.82%	41.66%	-7.14%	-3.24%	-3.82%	-2.52%
FCF Yield	-4.11%	-7.04%	-7.72%	-3.81%	-1.45%	-2.98%
Buyback Yield / Dilution	-0.02%	-	-	-13.99%	-8.19%	-0.42%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error